A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

AstraZeneca spinout Dizal Pharmaceuticals won an FDA accelerated approval for sunvozertinib for previously treated EGFR ex 20-mutated non-small cell lung cancer. To be marketed as Zegfrovy, the oral ...

Q: I have been caring for my 75-year-old husband with dementia for the past four years (I am 72), and I’m at my wits’ end.

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and ...

Q: I’m having some memory problems, and my doctor said to eat more salads. What does that have to do with anything? — Pat R., ...

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.